Skip to main content
WeightCited

DHEA para Abdominal Fat Reduction

C Evidencia Evidencia limitada de estudios pequeños, pero existen algunas señales positivas.

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Ddhea\u0026condition\u003Dabdominal\u002Dfat'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusión

An 8-week RCT (n=45) found 7-Keto DHEA plus exercise produced greater weight loss (2.88 kg vs. 0.97 kg placebo). Meta-analysis in elderly found modest abdominal fat reduction. Long-term safety is unclear and DHEA is banned by WADA.

Key Study Findings

Other n=60 7 weeks
Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing …
Dose: 200 mg/kg for 45 days vs: DHEA-induced PCOS model controls Outcome: PCOS attenuation via TLR4/MyD88/NF-kB pathway Efecto: BW p=0.025, testosterone p=0.005 <0.05 multiple endpoints

Población: DHEA-induced PCOS C57BL/6J mice (4 groups, n=15)

In Vitro 3.0 weeks
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Dose: 4 g vs: Control Outcome: Gut microbiota composition Efecto: None None

Población: None

Key Statistics

5

Estudios

200

Participantes

Positive

C

Calificación

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
25-50 mg/day DHEA
guidance:
Guided by serum DHEA-S levels
7ketodhea:
100 mg 2x/day

Límite superior: 50 mg/day for general use; higher doses under medical supervision only

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
200 mg/kg for 45 days 7 weeks Positive 60
4 g 3.0 weeks Positive --

Mejor momento para tomar: Morning (mimics natural diurnal pattern)

Safety & Side Effects

Efectos secundarios reportados

  • Acne
  • Hair loss
  • Facial hair growth (women)
  • Mood changes
  • Hormonal side effects

Interacciones conocidas

  • Hormone-sensitive cancers (avoid)
  • Antiestrogens (may counteract)
  • Insulin and diabetes medications
  • WADA-banned in competitive sports

Ingesta máxima tolerable: 50 mg/day for general use; higher doses under medical supervision only

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does DHEA help with Abdominal Fat Reduction?
Based on 5 studies with 200 participants, there is limited but promising evidence that DHEA may support Abdominal Fat Reduction management. Our evidence grade is C (Some Evidence).
How much DHEA should I take for Abdominal Fat Reduction?
Studies have used various dosages. A commonly studied range is 25-50 mg/day DHEA. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of DHEA?
Reported side effects may include Acne, Hair loss, Facial hair growth (women), Mood changes. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for DHEA and Abdominal Fat Reduction?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

References

  1. [1] Qin Yang et al.. Sci Rep. 2024. Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. doi:10.1038/s41598-024-81034-5 PubMed
  2. [2] Jing Xue et al.. Endocr J. 2019. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. doi:10.1507/endocrj.EJ18-0567 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.